• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WEB 2086(血小板活化因子拮抗剂)和酮洛芬(非甾体抗炎药)对血小板活化因子诱导的犊牛血小板形态超微结构变化的保护作用。

Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.

作者信息

da Silva M B, Dessy C, Coghe J, David J L, Lekeux P

机构信息

Department of Physiology, University of Liege, Belgium.

出版信息

Vet Res Commun. 1998 Jun;22(4):273-91. doi: 10.1023/a:1006007802126.

DOI:10.1023/a:1006007802126
PMID:9686442
Abstract

The ultrastructure of bovine platelets was examined by transmission electron microscopy without any pretreatment (control), and after WEB 2086 (a triazolodiazepine) or ketoprofen (NSAID) pretreatment, followed by PAF infusion. The blood platelet count was also investigated. The group of calves that received WEB 2086 pretreatment before platelet-activating factor (PAF) infusion did not show a decreased number of platelets. However, in the other group, with ketoprofen pretreatment before PAF infusion, there was a rapid decrease from 1 to 3 min, while from 5 min the number of platelets recovered to the normal value. Electron microscopy revealed that pretreatment with WEB 2086 followed by PAF infusion did not alter the morphological ultrastructure of bovine platelets, except that the microtubules were briefly modified from 1 until 3 min after PAF challenge. After ketoprofen pretreatment, bovine platelets kept their regular shape, the number of dense bodies was not significantly altered, the number of mitochondria was maintained from 5 min after PAF infusion, giant platelets were not observed and the Golgi apparatus was rarely visible. Thus pretreatment with WEB 2086 and ketoprofen before PAF infusion had a protective activity on the ultrastructure of bovine platelets and, in cattle, pretreatment with WEB 2086 and ketoprofen before PAF challenge prevented the thrombocytopenia induced by PAF.

摘要

通过透射电子显微镜对未经任何预处理(对照)、经WEB 2086(一种三唑并二氮杂䓬)或酮洛芬(非甾体抗炎药)预处理后再输注血小板活化因子(PAF)的牛血小板超微结构进行了检查。同时也对血小板计数进行了研究。在输注PAF前接受WEB 2086预处理的小牛组血小板数量未减少。然而,在另一组中,在输注PAF前用酮洛芬预处理,血小板数量在1至3分钟内迅速下降,而从5分钟起血小板数量恢复到正常值。电子显微镜显示,经WEB 2086预处理后再输注PAF,除了在PAF激发后1至3分钟微管有短暂改变外,并未改变牛血小板的形态超微结构。经酮洛芬预处理后,牛血小板保持其正常形状,致密体数量无明显改变,从输注PAF后5分钟起线粒体数量维持不变,未观察到巨型血小板,高尔基体也很少可见。因此,在输注PAF前用WEB 2086和酮洛芬预处理对牛血小板超微结构具有保护作用,并且在牛中,在PAF激发前用WEB 2086和酮洛芬预处理可预防PAF诱导的血小板减少。

相似文献

1
Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.WEB 2086(血小板活化因子拮抗剂)和酮洛芬(非甾体抗炎药)对血小板活化因子诱导的犊牛血小板形态超微结构变化的保护作用。
Vet Res Commun. 1998 Jun;22(4):273-91. doi: 10.1023/a:1006007802126.
2
Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves.
Vet Res. 1997 Sep-Oct;28(5):489-502.
3
Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.Web 2086(血小板活化因子拮抗剂)与酮洛芬(非甾体抗炎药)对牛体内血小板活化因子诱导的体外血小板聚集的联合作用
Zentralbl Veterinarmed A. 1997 Apr;44(2):65-71. doi: 10.1111/j.1439-0442.1997.tb01087.x.
4
Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.血小板激活因子受体拮抗剂WEB 2086在体外对牛体内PAF诱导的血小板聚集的抑制作用。
Zentralbl Veterinarmed A. 1996 Sep;43(7):399-413. doi: 10.1111/j.1439-0442.1996.tb00468.x.
5
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Vet Res Commun. 1997 Oct;21(7):521-31. doi: 10.1023/a:1005950622207.
6
Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.血小板活化因子拮抗剂WEB 2086及其杂氮䓬类似物与人类血小板和内皮细胞的相互作用。
Br J Pharmacol. 1989 Oct;98(2):653-61. doi: 10.1111/j.1476-5381.1989.tb12640.x.
7
The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF).
Thromb Res. 1988 Jul 15;51(2):219-23. doi: 10.1016/0049-3848(88)90065-5.
8
Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.血小板活化因子(PAF)新型特异性拮抗剂Y-24180的药理作用:II. 与PAF及苯二氮䓬受体的相互作用
Prostaglandins. 1990 Dec;40(6):571-83. doi: 10.1016/0090-6980(90)90002-d.
9
1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.1-O-十六烷基-2-乙酰基-sn-甘油-3-磷酸(N,N,N-三甲基)己醇胺:一种具有部分激动剂活性的血小板活化因子类似物。
Br J Pharmacol. 1991 Sep;104(1):171-7. doi: 10.1111/j.1476-5381.1991.tb12403.x.
10
Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.血小板活化因子在兔输注溶栓剂诱导的低血压和血小板活化中的作用。
Circ Res. 1993 Mar;72(3):658-70. doi: 10.1161/01.res.72.3.658.

本文引用的文献

1
Platelet-activating factor and cellular immune responses.血小板活化因子与细胞免疫反应。
Immunol Today. 1987;8(11):345-51. doi: 10.1016/0167-5699(87)90010-7.
2
Effect of ketoprofen on PAF-induced bovine platelet aggregation.酮洛芬对血小板活化因子诱导的牛血小板聚集的影响。
Vet J. 1998 Mar;155(2):201-3. doi: 10.1016/s1090-0233(98)80020-8.
3
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Vet Res Commun. 1997 Oct;21(7):521-31. doi: 10.1023/a:1005950622207.
4
Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves.
Vet Res. 1997 Sep-Oct;28(5):489-502.
5
Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.Web 2086(血小板活化因子拮抗剂)与酮洛芬(非甾体抗炎药)对牛体内血小板活化因子诱导的体外血小板聚集的联合作用
Zentralbl Veterinarmed A. 1997 Apr;44(2):65-71. doi: 10.1111/j.1439-0442.1997.tb01087.x.
6
Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.血小板激活因子受体拮抗剂WEB 2086在体外对牛体内PAF诱导的血小板聚集的抑制作用。
Zentralbl Veterinarmed A. 1996 Sep;43(7):399-413. doi: 10.1111/j.1439-0442.1996.tb00468.x.
7
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease.血小板活化因子对正常马匹及患有慢性阻塞性肺疾病的无症状马匹中放射性标记白细胞和血小板分布的影响。
Res Vet Sci. 1996 Sep;61(2):107-13. doi: 10.1016/s0034-5288(96)90083-1.
8
Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling.应用药代动力学/药效学模型研究酮洛芬在犊牛体内的药代动力学和药效学
J Vet Pharmacol Ther. 1995 Oct;18(5):315-24. doi: 10.1111/j.1365-2885.1995.tb00597.x.
9
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man.对伴侣动物、食用动物、水貂和人类血小板的花生四烯酸途径的评估。
Thromb Res. 1980 Oct 1;20(1):13-24. doi: 10.1016/0049-3848(80)90052-3.
10
Ultrastructure of resting and activated storage pool deficient platelets from animals with the Chédiak-Higashi syndrome.患有切-东综合征动物的静息和活化储存池缺陷血小板的超微结构
Am J Pathol. 1982 Mar;106(3):364-77.